Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Li Ning Company ( (HK:2331) ) has provided an update.
Li Ning Company has set new annual caps for 2026 under its Restricted Share (RS) Scheme, which is used to purchase company shares from the open market to satisfy the vesting of restricted shares granted to employees and other selected participants. For the period from 1 January to 31 December 2026, the board has approved a Number Annual Cap of 15 million shares and a Referable Amount Annual Cap of HK$300 million, with the effective limit being whichever is lower in value. Because the RS Scheme trustee is deemed an associate of the company’s connected persons, these purchases constitute continuing connected transactions under Hong Kong listing rules, triggering reporting, announcement and annual review obligations but remaining exempt from independent shareholder approval as all relevant percentage ratios are below 5%. The caps were set with reference to past grants, scheme limits, share price performance and anticipated future grants, and the company maintains governance safeguards requiring independent non-executive director approval for any restricted share grants to directors or administration committee members.
The most recent analyst rating on (HK:2331) stock is a Buy with a HK$19.50 price target. To see the full list of analyst forecasts on Li Ning Company stock, see the HK:2331 Stock Forecast page.
More about Li Ning Company
Li Ning Company Limited is a Hong Kong-listed sportswear company incorporated in the Cayman Islands, primarily engaged in the design, manufacture and retail of athletic footwear, apparel and related sporting goods, with its shares traded in both HKD and RMB counters on the Hong Kong Stock Exchange.
YTD Price Performance: -0.59%
Average Trading Volume: 17,976,572
Technical Sentiment Signal: Hold
Current Market Cap: HK$47.93B
For an in-depth examination of 2331 stock, go to TipRanks’ Overview page.

